FIELD: biology, gene engineering, in particular cationic lipid/protein/nucleic acid complex.
SUBSTANCE: invention relates to non-viral vector containing condensed polypeptide/nucleic acid complex and cationic lipid. Complex represents required nucleotide sequence and one or more nucleic acid packing viral polypeptides or derivatives thereof. Polypeptide/nucleic acid complex, method for production of non-viral vector and method for embedding of target nucleic acid into eucaryotic cell also are disclosed.
EFFECT: new non-viral vector useful in gene engineering investigations.
14 cl, 25 dwg, 14 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING LIPIDS CARRYING POLAR AND NONPOLAR FRAGMENT | 2002 |
|
RU2294738C2 |
METHOD FOR PREPARING COMPOUNDS, COMPOSITION FOR PREPARING MEDICINAL AGENT | 2001 |
|
RU2290409C2 |
STABILIZATION OF COMPOSITIONS "LIPID : DNA" IN SPRAYING PROCESS | 1999 |
|
RU2213578C2 |
MEAN FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO CELLS OF MAMMALS | 2014 |
|
RU2572575C1 |
PEPTIDES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2020 |
|
RU2771605C2 |
NUCLEIC ACID DELIVERY SYSTEM | 2002 |
|
RU2294192C2 |
COMPOSITIONS POLYETHYLENEIMINE : DNA FOR AEROSOL DELIVERY | 2000 |
|
RU2242970C2 |
CARRIER FOR TARGETED DELIVERY OF NUCLEIC ACIDS TO CELLS EXPRESSING RECEPTOR CXCR4 | 2012 |
|
RU2522810C1 |
UNCHARGED LIPID, COMPOSITION BASED ON IT WITH POLYCATIONIC AMPHIPHILIC MOLECULE, AND NEUTRAL PHOSPHOLIPID, AND METHOD FOR ITS PREPARATION FOR DELIVERY OF NUCLEIC ACIDS IN VITRO | 2020 |
|
RU2747559C1 |
NUCLEIC ACID COMPLEX AND COMPOSITION FOR NUCLEIC ACID DELIVERY | 2008 |
|
RU2465009C2 |
Authors
Dates
2006-01-10—Published
2000-12-12—Filed